Successful treatment with adefovir dipivoxil in a patient with fibrosing cholestatic hepatitis and lamivudine resistant hepatitis B virus
about
Direct acting antivirals for the treatment of chronic viral hepatitisEpidemiology of primary and secondary liver cancers.Chronic hepatitis B: current and future treatment options.Investigational pharmacologic treatment for liver disease.Hepatitis B: progress in the last 15 years.Hepatitis B immune globulin for life versus limited use: I favor limited duration of therapy.Hepatitis B virus resistance to lamivudine and its clinical implications.Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era.Hepatitis infection in the treatment of opioid dependence and abuse.Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.Adefovir dipivoxil in the treatment of chronic hepatitis B.Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections.Review article: Nucleoside analogues for the treatment of chronic hepatitis B.Treatment of hepatitis B and C after liver transplantation. Part 1, hepatitis B.Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analoguesFibrosing cholestatic hepatitis: clinicopathologic spectrum, diagnosis and pathogenesis.Current antiviral therapies for chronic hepatitis B.Treatment of recurrent hepatitis B infection in liver transplant recipients.Fibrosing Cholestatic Hepatitis Following Renal Transplantation in a Patient Infected With the Hepatitis B Virus.Beneficial effect of lamivudine for hepatitis B transplant recipients.Effect of lamivudine treatment in patients with decompensated cirrhosis due to anti-HBe positive/HBeAg-negative chronic hepatitis B.A novel model for evaluating the risk of hepatitis B recurrence after liver transplantation.Evolution of hepatitis B viral load and viral genome sequence during adefovir dipivoxil therapy.Outcome of lamivudine resistant hepatitis B virus mutant post-liver transplantation on lamivudine monoprophylaxis.Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.
P2860
Q27022216-24985E45-2D98-4868-942E-5824AF79294AQ34563350-3D7BA8BE-750E-43F4-9C0B-92CC1C5CD8D7Q34687438-D0D4716E-DFBE-4716-9915-9B13F5DEEC9DQ34841865-EEC5705C-EC3D-45A8-8097-12F7D6982B0AQ34936238-1ABFAF55-D67E-4201-8DFA-45BE5DD4D0BFQ34936305-A6076EB5-4B64-49FE-B0EC-3183D635DDBEQ35007583-0769C300-7B3E-4C54-AACD-FE92DF5403C9Q35076630-F39B7C4D-164A-45FF-90A0-8A3B704C61E7Q35389163-5992AFA6-A4E9-4427-A791-283F7086E67BQ35558801-720C73E6-9899-41BD-80A4-4634ADB16ACFQ35678267-FE4E01F7-2F13-444A-AF40-CE218EB1157AQ35917125-345C2919-D066-4A9B-945F-F34BDD657007Q35987869-3C87E31E-F155-4737-9EC2-0542EAF540FCQ36028324-05DAEEB4-DF15-4EF6-80F7-4B39A461D431Q36442537-2336DFEF-6B3C-4C6E-AB02-55302150775AQ37267233-619D0067-4FA5-4A11-B40A-49E49135BAE8Q40096242-1225F552-E337-44D8-8905-FC8D0C45774AQ40629253-4D88034E-4AC4-42D2-82B6-05B3636EAA5FQ42122536-D54DF25E-C477-44D9-91C2-4A64146E27D1Q43988925-DF0C11C5-400A-40CE-AD50-BF3C356D203FQ44018025-55DCBF16-C0BE-4274-A936-E9038069E555Q44179156-17A7674A-93F1-4305-A941-129E9F815580Q44738460-489C9450-8256-4FDB-A6AB-513702D48F0BQ44895107-F6F1A1F7-5C4A-49C1-98CE-15FFA8CD94D8Q45399119-CAF8F646-6795-4E96-9328-7F5E817E1291
P2860
Successful treatment with adefovir dipivoxil in a patient with fibrosing cholestatic hepatitis and lamivudine resistant hepatitis B virus
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Successful treatment with adef ...... ne resistant hepatitis B virus
@ast
Successful treatment with adef ...... ne resistant hepatitis B virus
@en
Successful treatment with adef ...... ne resistant hepatitis B virus
@nl
type
label
Successful treatment with adef ...... ne resistant hepatitis B virus
@ast
Successful treatment with adef ...... ne resistant hepatitis B virus
@en
Successful treatment with adef ...... ne resistant hepatitis B virus
@nl
prefLabel
Successful treatment with adef ...... ne resistant hepatitis B virus
@ast
Successful treatment with adef ...... ne resistant hepatitis B virus
@en
Successful treatment with adef ...... ne resistant hepatitis B virus
@nl
P2093
P356
P1433
P1476
Successful treatment with adef ...... ne resistant hepatitis B virus
@en
P2093
P304
P356
10.1136/GUT.49.3.436
P407
P577
2001-09-01T00:00:00Z